Med Biogene soars 28.6% March 22, 2017 17:00 EDT
CANADIAN DAILY STOCK REPORT
Med Biogene Inc. (TSXV:MBI), Canada's 10th largest Medical diagnostics & research company by market cap, has soared 1.0c (28.6%) from its last trading session of March 21 to close at 4.50c. Compared with the S&P/TSX 60 Index which rose 3.1 points (0.3%) in the day, the relative price increase was 28.2%. The volume was 0.1 times the average daily trading volume of 136,213 shares.
MED BIOGENE BULLISH SIGNALS